WASHINGTON--(BUSINESS WIRE)--Russell M. Medford, MD, PhD, President and CEO of Salutria Pharmaceuticals, LLC provided testimony on Wednesday, November 16 to the Presidential Commission for the Study of Bioethical Issues on BIO’s Principles Regarding Ethical Performance of International Clinical Trials. Dr. Medford is co-chair of BIO’s Board Standing Committee on Bioethics.
